• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对大流行相关的抗微生物药物耐药性继发性细菌感染,宿主免疫调节策略。

Host immunomodulation strategies to combat pandemic-associated antimicrobial-resistant secondary bacterial infections.

机构信息

Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan, Korea.

Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan, Korea.

出版信息

Int J Antimicrob Agents. 2024 Oct;64(4):107308. doi: 10.1016/j.ijantimicag.2024.107308. Epub 2024 Aug 19.

DOI:10.1016/j.ijantimicag.2024.107308
PMID:39168417
Abstract

The incidence of secondary bacterial infections has increased in recent decades owing to various viral pandemics. These infections further increase the morbidity and mortality rates associated with viral infections and remain a significant challenge in clinical practice. Intensive antibiotic therapy has mitigated the threat of such infections; however, overuse and misuse of antibiotics have resulted in poor outcomes, such as inducing the emergence of bacterial populations with antimicrobial resistance (AMR) and reducing the therapeutic options for this crisis. Several antibiotic substitutes have been suggested and employed; however, they have certain limitations and novel alternatives are urgently required. This review highlights host immunomodulation as a promising strategy against secondary bacterial infections to overcome AMR. The definition and risk factors of secondary bacterial infections, features and limitations of currently available therapeutic strategies, host immune responses, and future perspectives for treating such infections are discussed.

摘要

近年来,由于各种病毒大流行,继发细菌性感染的发病率有所增加。这些感染进一步增加了与病毒感染相关的发病率和死亡率,并且仍然是临床实践中的重大挑战。强化抗生素治疗减轻了此类感染的威胁;但是,抗生素的过度使用和误用导致了不良后果,例如导致具有抗微生物耐药性(AMR)的细菌种群的出现,并减少了应对这种危机的治疗选择。已经提出并采用了几种抗生素替代品;但是,它们具有一定的局限性,迫切需要新的替代品。这篇综述强调了宿主免疫调节作为一种有前途的策略来对抗继发细菌性感染以克服 AMR。讨论了继发细菌性感染的定义和危险因素、现有治疗策略的特征和局限性、宿主免疫反应以及治疗此类感染的未来展望。

相似文献

1
Host immunomodulation strategies to combat pandemic-associated antimicrobial-resistant secondary bacterial infections.针对大流行相关的抗微生物药物耐药性继发性细菌感染,宿主免疫调节策略。
Int J Antimicrob Agents. 2024 Oct;64(4):107308. doi: 10.1016/j.ijantimicag.2024.107308. Epub 2024 Aug 19.
2
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗?
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
3
Bacterial co-infections with SARS-CoV-2.细菌合并感染 SARS-CoV-2。
IUBMB Life. 2020 Oct;72(10):2097-2111. doi: 10.1002/iub.2356. Epub 2020 Aug 8.
4
Impact of vaccines on antimicrobial resistance.疫苗对抗微生物药物耐药性的影响。
Int J Infect Dis. 2020 Jan;90:188-196. doi: 10.1016/j.ijid.2019.10.005. Epub 2019 Oct 14.
5
Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.新冠病毒感染患者的细菌合并感染率和抗生素使用模式:系统评价和荟萃分析。
PLoS One. 2022 Aug 1;17(8):e0272375. doi: 10.1371/journal.pone.0272375. eCollection 2022.
6
Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection.与 2019 年冠状病毒病感染相关的细菌合并感染和抗菌药物耐药性。
Biotechnol Genet Eng Rev. 2023 Oct;39(2):259-280. doi: 10.1080/02648725.2022.2122297. Epub 2022 Sep 19.
7
The Building Blocks of Antimicrobial Resistance in : Implications for Current Resistance-Breaking Therapies.抗菌药物耐药性的构成要素:对当前抗耐药性治疗的启示
Front Cell Infect Microbiol. 2021 Apr 16;11:665759. doi: 10.3389/fcimb.2021.665759. eCollection 2021.
8
Significance of understanding the genomics of host-pathogen interaction in limiting antibiotic resistance development: lessons from COVID-19 pandemic.了解宿主-病原体相互作用的基因组学在限制抗生素耐药性发展方面的意义:从 COVID-19 大流行中吸取的教训。
Brief Funct Genomics. 2024 Jan 18;23(1):69-74. doi: 10.1093/bfgp/elad001.
9
Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends.COVID-19 癌症患者的细菌合并感染:预测因素和抗菌药物耐药趋势。
J Infect Dev Ctries. 2024 Aug 31;18(8):1185-1195. doi: 10.3855/jidc.19731.
10
Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens.治疗多重耐药细菌病原体引起的感染的新方法。
Future Med Chem. 2022 Aug;14(15):1133-1148. doi: 10.4155/fmc-2022-0029. Epub 2022 Jul 21.

引用本文的文献

1
Tiny but Mighty: Small RNAs-The Micromanagers of Bacterial Survival, Virulence, and Host-Pathogen Interactions.微小却强大:小RNA——细菌生存、毒力及宿主-病原体相互作用的微观管理者
Noncoding RNA. 2025 May 5;11(3):36. doi: 10.3390/ncrna11030036.
2
Synthesis of metal nanoparticles on graphene oxide and antibacterial properties.氧化石墨烯上金属纳米颗粒的合成及其抗菌性能
Front Chem. 2024 Oct 14;12:1426179. doi: 10.3389/fchem.2024.1426179. eCollection 2024.